iSpecimen Inc. (NasdaqCM: ISPC)
Health Care · Health Care Technology · US
$1.50
-11.24% today · -94.9% 1Y
iSpecimen Inc. (NasdaqCM: ISPC) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $4.11M and employs 7 people.
Over the last twelve months the share price has lost 94.9%, trading between 1.57 and 127.20.
Tweenvest scores iSpecimen Inc. across four factors: quality 27/100, value 44/100, growth 0/100. Its strongest factor is value.
ISPC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.11M
- Revenue (TTM)
- $466.30K
- P/E
- —
- EPS
- -21.95
- Dividend yield
- —
- Beta (5Y)
- 1.63
- 52-week high
- $127.20
- 52-week low
- $1.57
- Avg volume (3M)
- —
- Shares outstanding
- 2.43M
- Employees
- 7
- Next earnings
- —
About iSpecimen Inc.
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
- ISIN
- US45032V3069
- Founded
- 2009
- Listed since
- Jun 17, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Veeva Systems Inc.NYSE: VEEV | $40.36B | $244.03 | -1.78% |
| Pro Medicus LimitedASX: PME | $14.46B | AU$193.43 | +0.96% |
| M3, Inc.TSE: 2413 | $7.21B | ¥1,719.50 | +0.67% |
| Sectra AB (publ)OM: SECT B | $5.60B | Skr275.80 | -0.79% |
| Waystar Holding Corp.NasdaqGS: WAY | $4.86B | $25.23 | -0.47% |
| Doximity, Inc.NYSE: DOCS | $4.51B | $24.83 | -1.86% |
| HeartFlow, Inc.NasdaqGS: HTFL | $4.37B | $50.62 | +0.84% |
| Inventurus Knowledge Solutions LimitedNSEI: IKS | $3.30B | Rs1,840.00 | +6.43% |
Figures last refreshed Aug 18, 2026.